J Zang, Y Mei, S Zhu, S Yin, N Feng,
T Ci, Y Lyu - Pharmaceutics, 2024 - mdpi.com
Immunotherapy has been a research hotspot due to its low side effects, long-lasting efficacy,
and wide anti-tumor spectrum. Recently, NK cell-based immunotherapy has gained broad …